315 related articles for article (PubMed ID: 8759639)
1. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and some biological properties of the hexapeptide analog of substance P with a C-terminal thioamide group.
Kruszyński M; Kupryszewski G; Misterek K; Gumułka S
Pol J Pharmacol Pharm; 1990; 42(5):483-90. PubMed ID: 1711685
[TBL] [Abstract][Full Text] [Related]
3. Backbone cyclization of the C-terminal part of substance P. Part 1: The important role of the sulphur in position 11.
Bitan G; Zeltser I; Byk G; Halle D; Mashriki Y; Gluhov EV; Sukhotinsky I; Hanani M; Selinger Z; Gilon C
J Pept Sci; 1996; 2(4):261-9. PubMed ID: 9231334
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological activity, and conformational analysis of [pGlu6,N-MePhe8,Aib9] substance P (6-11): a selective agonist for the NK-3 receptor.
Tallon M; Ron D; Halle D; Amodeo P; Saviano G; Temussi PA; Selinger Z; Naider F; Chorev M
Biopolymers; 1993 Jun; 33(6):915-26. PubMed ID: 7686410
[TBL] [Abstract][Full Text] [Related]
6. [Cyclic analogs of substance P. I. Cyclo(11----epsilon 5)-[Lys5] substance P-(5-11)].
Maurops GKh; Mutulis FK; Rozite SKh; Myshliakova NV; Svirskis ShV
Bioorg Khim; 1987 Dec; 13(12):1619-28. PubMed ID: 2453193
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis of cyclic and non-cyclic tachykinin partial sequences. 2. Synthesis of the homocyclic substance P(6-11) hexapeptide].
Neubert K; Hartrodt B; Mehlis B; Rüger M; Bergmann J; Lindau J; Jakubke HD; Barth A
Pharmazie; 1985 Aug; 40(8):532-5. PubMed ID: 2417264
[TBL] [Abstract][Full Text] [Related]
9. [Cyclic analogs of substance P. III. Cyclo (6(sup)gamma----oligomethylenediamine----11) substance P(6-11)-hexapeptides].
Mutulis FK; Mutule IE; Maurops GKh; Bergmann Iu; Myshliakova NV; Strazda GM; Liepin'sh EE; Saulitis IuB; Grigor'eva VD; Balodis IuIu
Bioorg Khim; 1991 Oct; 17(10):1412-23. PubMed ID: 1725106
[TBL] [Abstract][Full Text] [Related]
10. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
Hess S; Ovadia O; Shalev DE; Senderovich H; Qadri B; Yehezkel T; Salitra Y; Sheynis T; Jelinek R; Gilon C; Hoffman A
J Med Chem; 2007 Nov; 50(24):6201-11. PubMed ID: 17983214
[TBL] [Abstract][Full Text] [Related]
11. Backbone cyclization: A new method for conferring conformational constraint on peptides.
Gilon C; Halle D; Chorev M; Selinger Z; Byk G
Biopolymers; 1991 May; 31(6):745-50. PubMed ID: 1718473
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of novel backbone-bicyclic substance-P analogs containing lactam and disulfide bridges.
Bitan G; Sukhotinsky I; Mashriki Y; Hanani M; Selinger Z; Gilon C
J Pept Res; 1997 May; 49(5):421-6. PubMed ID: 9211223
[TBL] [Abstract][Full Text] [Related]
14. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements.
De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G
Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109
[TBL] [Abstract][Full Text] [Related]
15. Cyclic pentapeptides of chiral sequence DLDDL as scaffold for antagonism of G-protein coupled receptors: synthesis, activity and conformational analysis by NMR and molecular dynamics of ITF 1565 a substance P inhibitor.
Porcelli M; Casu M; Lai A; Saba G; Pinori M; Cappelletti S; Mascagni P
Biopolymers; 1999 Aug; 50(2):211-9. PubMed ID: 10380345
[TBL] [Abstract][Full Text] [Related]
16. Conformation-activity relationship in hexapeptides related to substance P.
Elguero J; García-Antón JM; Goya P; Haro I; Martínez A; Reig F
Arzneimittelforschung; 1989 Aug; 39(8):835-8. PubMed ID: 2479388
[TBL] [Abstract][Full Text] [Related]
17. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
Felix AM; Lu YA; Campbell RM
Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and biological activity of cyclic and linear analogs of C-terminal fragments of neurotensin].
Grinshteĭne IV; Misinia IP; Vegner RE; Vosekalna IA; Gaĭlite EA
Bioorg Khim; 1985 Sep; 11(9):1167-79. PubMed ID: 4062994
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
[TBL] [Abstract][Full Text] [Related]
20. Conformational analysis of the C-terminal Gly-Leu-Met-NH2 tripeptide of substance P bound to the NK-1 receptor.
Sagan S; Quancard J; Lequin O; Karoyan P; Chassaing G; Lavielle S
Chem Biol; 2005 May; 12(5):555-65. PubMed ID: 15911376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
